Heier, Christopher R <br/><br/>
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy.  [electronic resource] 

 -  Life science alliance  02 2019 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>2575-1077 
<br/><br/><label>Standard No.: </label>10.26508/lsa.201800186  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aldosterone--chemistry<br/>Animals<br/>Anti-Inflammatory Agents--chemistry<br/>CRISPR-Associated Protein 9--genetics<br/>Cardiomyopathies--drug therapy<br/>Computer Simulation<br/>Disease Models, Animal<br/>Eplerenone--chemistry<br/>Gene Knockout Techniques<br/>Hydrogen Bonding<br/>Macrophages--drug effects<br/>Mice<br/>Mice, Inbred C57BL<br/>Mineralocorticoid Receptor Antagonists--chemistry<br/>Muscular Dystrophy, Duchenne--drug therapy<br/>Myocarditis--drug therapy<br/>Myocytes, Cardiac--drug effects<br/>Prednisolone--chemistry<br/>Pregnadienediols--chemistry<br/>RAW 264.7 Cells<br/>Receptors, Glucocorticoid--chemistry<br/>Receptors, Mineralocorticoid--agonists